BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30307401)

  • 1. miRNAs as biofluid markers for diagnostics of Alzheimer's disease: recent status and perspectives.
    Kosikova N; Cente M; Cigankova V; Koson P; Filipcik P
    Gen Physiol Biophys; 2018 Sep; 37(5):495-514. PubMed ID: 30307401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease.
    Van Giau V; An SS
    J Neurol Sci; 2016 Jan; 360():141-52. PubMed ID: 26723991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA diagnostic panel for Alzheimer's disease and epigenetic trade-off between neurodegeneration and cancer.
    Nagaraj S; Zoltowska KM; Laskowska-Kaszub K; Wojda U
    Ageing Res Rev; 2019 Jan; 49():125-143. PubMed ID: 30391753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of Alzheimer's disease in body fluids.
    Zheng Y; He J; Hong T
    Sci China Life Sci; 2010 Apr; 53(4):490-6. PubMed ID: 20596916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNAs as Early Biomarkers of Alzheimer's Disease: A Synaptic Perspective.
    Siedlecki-Wullich D; Miñano-Molina AJ; Rodríguez-Álvarez J
    Cells; 2021 Jan; 10(1):. PubMed ID: 33435363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs in Alzheimer Disease - A Therapeutic Perspective.
    Gupta P; Bhattacharjee S; Sharma AR; Sharma G; Lee SS; Chakraborty C
    Curr Alzheimer Res; 2017; 14(11):1198-1206. PubMed ID: 28847283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease: presence and role of microRNAs.
    Basavaraju M; de Lencastre A
    Biomol Concepts; 2016 Aug; 7(4):241-52. PubMed ID: 27505094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in Sporadic and Familial Alzheimer's Disease.
    Lista S; O'Bryant SE; Blennow K; Dubois B; Hugon J; Zetterberg H; Hampel H
    J Alzheimers Dis; 2015; 47(2):291-317. PubMed ID: 26401553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β as a biomarker for Alzheimer's disease: quantification methods in body fluids.
    Galozzi S; Marcus K; Barkovits K
    Expert Rev Proteomics; 2015 Aug; 12(4):343-54. PubMed ID: 26153725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs as novel biomarkers of Alzheimer's disease.
    Zendjabil M
    Clin Chim Acta; 2018 Sep; 484():99-104. PubMed ID: 29800558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for preclinical Alzheimer's disease.
    Tan CC; Yu JT; Tan L
    J Alzheimers Dis; 2014; 42(4):1051-69. PubMed ID: 25024325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Biomarker Panels in Alzheimer's Disease.
    Zafari S; Backes C; Meese E; Keller A
    Gerontology; 2015; 61(6):497-503. PubMed ID: 25720553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.
    Pan Y; Liu R; Terpstra E; Wang Y; Qiao F; Wang J; Tong Y; Pan B
    J Alzheimers Dis; 2016; 49(1):1-12. PubMed ID: 26484912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
    Dong H; Li J; Huang L; Chen X; Li D; Wang T; Hu C; Xu J; Zhang C; Zen K; Xiao S; Yan Q; Wang C; Zhang CY
    Dis Markers; 2015; 2015():625659. PubMed ID: 26078483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review.
    Wu HZ; Ong KL; Seeher K; Armstrong NJ; Thalamuthu A; Brodaty H; Sachdev P; Mather K
    J Alzheimers Dis; 2016; 49(3):755-66. PubMed ID: 26484928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic-guided discovery of Alzheimer's disease biomarkers from body fluid.
    Enche Ady CNA; Lim SM; Teh LK; Salleh MZ; Chin AV; Tan MP; Poi PJH; Kamaruzzaman SB; Abdul Majeed AB; Ramasamy K
    J Neurosci Res; 2017 Oct; 95(10):2005-2024. PubMed ID: 28301062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretases-related miRNAs in Alzheimer's disease: new approach for biomarker discovery.
    Hajjari SN; Mehdizadeh M; Sadigh-Eteghad S; Shanehbandi D; Teimourian S; Baradaran B
    Neurol Sci; 2017 Nov; 38(11):1921-1926. PubMed ID: 28791490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface protein profiling and subtyping of extracellular vesicles in body fluids reveals non-CSF biomarkers of Alzheimer's disease.
    Cai Y; Chen T; Cai Y; Liu J; Yu B; Fan Y; Su J; Zeng Y; Xiao X; Ren L; Tang Y
    J Extracell Vesicles; 2024 Apr; 13(4):e12432. PubMed ID: 38602321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease.
    Rahmadi A; Steiner N; Münch G
    Clin Chem Lab Med; 2011 Mar; 49(3):385-91. PubMed ID: 21275816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Alzheimer's Disease-related miRNA Based on Semi-clustering.
    Zhao T; Wang D; Hu Y; Zhang N; Zang T; Wang Y
    Curr Gene Ther; 2019; 19(4):216-223. PubMed ID: 31549953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.